Publications

  1. Hadani Y, Tarikogullari I, Oesterle TS, McGinnis MT, Nidey N, Lai B, Kalata AH, Sharma P, Bormann NL. Care coordination in screening, brief intervention, and referral to treatment (SBIRT): A scoping review. Am J Addict 2026 Jan; 35 (1):22-35 Epub 2025 Nov 23
    View PubMed
  2. Oesterle TS, Bormann NL. Digital Therapies for Substance Use Disorders: Recent Advances and Engagement Strategies. Subst Abuse Rehabil. 2026; 17:560350 Epub 2026 Feb 27
    View PubMed
  3. Correa da Costa S, Bormann NL, Oesterle T, McGinnis MT, Ho MF, Vettleson-Trutza SA, Rummans T, Gold MS. The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews. Brain Sci. 2025 Sep 28; 15 (10) Epub 2025 Sept 28
    View PubMed
  4. Weber AN, Osman M, Smeins L, Chawla S, Thomas MM, Arndt S, Bormann NL. Integrated approaches to reduce alcohol use in people with liver disease: a scoping review and quantitative analysis. Alcohol Alcohol 2025 Sep 16; 60 (6)
    View PubMed
  5. Bormann NL, Black DW. Pseudohallucinations: A Review and Reappraisal Annals of Clinical Psychiatry. 2025.
  6. Oesterle TS, Bormann NL, Al-Soleiti M, Kung S, Singh B, McGinnis MT, Correa da Costa S, Rummans T, Chauhan M, Rojas Cabrera JM, Vettleson-Trutza SA, Scheitler KM, Shin H, Lee KH, Gold MS. Invasive and Non-Invasive Neuromodulation for the Treatment of Substance Use Disorders: A Review of Reviews. Brain Sci. 2025 Jul 6; 15 (7) Epub 2025 July 06
    View PubMed
  7. Bormann NL, Burson JR, Burson EM, McGinnis M, Karpyak V, Coombes BJ, Gold M, Oesterle TS. How Treatment-Refractory Addiction Is Defined: A Scoping Review. J Addict Med. 2025 Jun 10 Epub 2025 June 10
    View PubMed
  8. Bormann NL, Oesterle TS, Weber AN, Choi DS, Karpyak V, Arndt S. Positive changes in employment status are associated with reduced alcohol use frequency at discharge from outpatient specialty treatment. Alcohol Clin Exp Res (Hoboken). 2025 Jun; 49 (6):1286-1296 Epub 2025 May 30
    View PubMed
  9. Oesterle TS, Bormann NL, Paul MM, Breitinger SA, Lai B, Smith JL, Stoppel CJ, Arndt S, Williams MD. Treatment of Substance Use Disorders With a Mobile Phone App Within Rural Collaborative Care Management (Senyo Health): Protocol for a Mixed Methods Randomized Controlled Trial. JMIR Res Protoc. 2025 Mar 26; 14:e65693
    View PubMed
  10. Yang MA, Kang S, Hong SI, Lee J, Bormann NL, Lee SW, Choi DS. Astrocytes in the External Globus Pallidus Selectively Represent Routine Formation During Repeated Reward-Seeking in Mice. eNeuro. 2025 Mar; 12 (3) Epub 2025 Mar 17
    View PubMed
  11. Peng L, Bormann NL, Arndt S, Miskle BA, Weber AN. Patient Perspectives on a Rapid Access, Walk-in, Medication for Addiction Treatment Clinic. Subst Abuse Rehabil. 2025; 16:119-128 Epub 2025 May 01
    View PubMed
  12. Trimble EA, Bormann NL, Kalata AH, Gerberi D, Arndt S, Oesterle TS. Hybrid Virtual Group Model for Substance Use Disorder Therapy: A Scoping Review. Subst Abuse Rehabil. 2025; 16:137-146 Epub 2025 May 14
    View PubMed
  13. Bormann NL, Weber AN, Oesterle TS, Miskle B, Lynch AC, Arndt S. State inequities: Gaps in planned treatment for criminal legal referrals with opioid use disorder across two decades of US treatment admissions. Am J Addict. 2025 Jan; 34 (1):60-68 Epub 2024 Aug 03
    View PubMed
  14. Bormann NL, Oesterle TS, Lifson MA, Choi DS, Arndt S. Sex, Race, and Ethnicity as Intersectional Predictors of Outpatient Substance Use Disorder Treatment Attrition. Subst Abuse Rehabil. 2025; 16:257-269 Epub 2025 Oct 10
    View PubMed
  15. Volker KM, Prechtl BLH, Bormann NL, Choi DS. The potential role of GLP-1 receptor agonists in substance use disorders - a systematic review. Front Pharmacol. 2025; 16:1702448 Epub 2026 Jan 02
    View PubMed
  16. Essa H, Ali HM, Min PH, Ali DN, Lowe V, Petersen RC, Knopman DS, Lundt ES, Mester CT, Bormann NL, Choi DS. Impact of alcohol use disorder on cognition in correlation with aging: a community-based retrospective cohort study. Alcohol Alcohol. 2024 Nov 18; 60(1).
    View PubMed
  17. Oesterle TS, Hall-Flavin DK, Bormann NL, Loukianova LL, Fipps DC, Breitinger SA, Gilliam WP, Wu T, da Costa SC, Arndt S, Karpyak VM. Therapeutic Content of Mobile Phone Applications for Substance Use Disorders: An Umbrella Review. Mayo Clin Proc Digit Health. 2024 Jun; 2 (2):192-206 Epub 2024 Apr 11
    View PubMed
  18. Bormann NL, Oesterle TS, Arndt S, Karpyak VM, Croarkin PE. Systematic review and meta-analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders. Am J Addict. 2024 May; 33 (3):269-282 Epub 2024 Jan 25
    View PubMed
  19. Bormann NL, Arndt S. Evidence of "Repeated Admission Bias" Among Those Who Use Injection Drugs Across 2 Decades of US Treatment Admissions: 2000-2020. J Addict Med. 2024 Jan 16 [Epub ahead of print]
    View PubMed
  20. Bormann NL, Stoppel CJ, Arndt S, Oesterle TS. Patient Perceived Impact of Outpatient Group Substance Use Disorder Treatment in a Hybrid Model or Virtual-Only Model Relative to In-Person Delivery. Subst Abuse Rehabil. 2024; 15:223-232 Epub 2024 Oct 25
    View PubMed
  21. Weber AN, Trebach J, Brenner MA, Thomas MM, Bormann NL. Managing Opioid Withdrawal Symptoms During the Fentanyl Crisis: A Review. Subst Abuse Rehabil. 2024; 15:59-71 Epub 2024 Apr 10
    View PubMed
  22. Oesterle TS, Bormann NL, Ochal DA, Arndt S, Breitinger SA. Transitioning Virtual-Only Group Therapy for Substance Use Disorder Patients to a Hybrid Model. Subst Abuse Rehabil. 2024; 15:73-78 Epub 2024 Apr 23
    View PubMed
  23. Weber AN, Arndt S, Miskle B, Bormann NL. Mortality in Treatment-seeking Older Adults Receiving Medications for Opioid Use Disorder. J Addict Med. 2023 Dec 12 [Epub ahead of print]
    View PubMed
  24. Bormann NL, Miskle B, Holdefer P, Arndt S, Lynch AC, Weber AN. Evidence of telescoping in females across two decades of US treatment admissions for injection drug use: 2000-2020. Drug Alcohol Depend Rep. 2023 Dec; 9:100204 Epub 2023 Nov 10
    View PubMed
  25. Bormann NL, Weber A, Miskle B, Arndt S, Lynch A. Improved recovery capital correlates with reduced methamphetamine use and crime in the community J Addict Med. 2023.
    View PubMed
  26. Bormann NL, Chambers RA. Esketamine effects on buprenorphine treatment in a comorbid case of opioid addiction, with depression, Obsessive-compulsive disorder, and chronic pain J Pharmacol Clin Toxicol. 2023.
  27. Bormann NL, Weber AN, Arndt S, Lynch A. Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment-seeking cohort. Am J Addict. 2023 May 2 Epub 2023 May 02
    View PubMed
  28. Bormann NL, Weber AN, Miskle B, Woodson-DeFauw N, Arndt S, Lynch AC. Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data. Soc Psychiatry Psychiatr Epidemiol. 2023 Mar 6 Epub 2023 Mar 06
    View PubMed
  29. Bormann NL, Weber AN, Miskle B, Arndt S, Lynch AC. Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder. Subst Abuse Rehabil. 2023; 14:113-118 Epub 2023 Oct 05
    View PubMed
  30. Bormann NL, Weber AN, Miskle B, Arndt S, Lynch AC. Sex Differences in Recovery Capital Gains Post-Incarceration. Subst Use Misuse. 2023; 58 (14):1839-1846 Epub 2023 Sept 13
    View PubMed
  31. Bormann NL, Gout A, Kijewski V, Lynch A. Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine. F1000Res. 2022; 11:487 Epub 2023 Aug 10
    View PubMed
  32. Black DW, Allen J, Bormann NL. Are Comorbid Disorders Associated with Changes in Gambling Activity? A Longitudinal Study of Younger and Older Subjects with DSM-IV Pathological Gambling. J Gambl Stud. 2021 Dec; 37 (4):1219-1230 Epub 2021 Jan 21
    View PubMed
  33. Bormann NL, Trapp NT, Narayanan NS, Boes AD. Developing Precision Invasive Neuromodulation for Psychiatry. J Neuropsychiatry Clin Neurosci. 2021 Summer; 33 (3):201-209 Epub 2021 May 14
    View PubMed
  34. Wanzek R, Bormann N, Shabbir Y, Saito T, Yamada T, Shinozaki G. Increased mortality in patients with standard EEG findings of 'diffuse slowing'. Ann Clin Psychiatry. 2021 Feb 1; 33 (1):e14-e21 Epub 2021 Feb 01
    View PubMed
  35. Borcherding N, Crotts SB, Ortolan LS, Henderson N, Bormann NL, Jabbari A. A transcriptomic map of murine and human alopecia areata. JCI Insight. 2020 Jul 9; 5 (13) Epub 2020 July 09
    View PubMed
  36. Borcherding N, Bormann NL, Kraus G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res. 2020; 9:47 Epub 2020 Jan 27
    View PubMed
  37. Shinozaki G, Bormann NL, Chan AC, Zarei K, Sparr NA, Klisares MJ, Jellison SS, Heinzman JT, Dahlstrom EB, Duncan GN, Gaul LN, Wanzek RJ, Cramer EM, Wimmel CG, Sabbagh S, Yuki K, Weckmann MT, Yamada T, Karam MD, Noiseux NO, Shinozaki E, Cho HR, Lee S, Cromwell JW. Identification of Patients With High Mortality Risk and Prediction of Outcomes in Delirium by Bispectral EEG. J Clin Psychiatry. 2019 Sep 3; 80 (5) Epub 2019 Sept 03
    View PubMed
  38. Bormann NL, Allen J, Shaw M, Black DW. Religiosity and Chance Beliefs in Persons with DSM-IV Pathological Gambling Enrolled in a Longitudinal Follow-Up Study. J Gambl Stud. 2019 Sep; 35 (3):849-860
    View PubMed
  39. Kolb R, Kluz P, Tan ZW, Borcherding N, Bormann N, Vishwakarma A, Balcziak L, Zhu P, Davies BS, Gourronc F, Liu LZ, Ge X, Jiang BH, Gibson-Corley K, Klingelhutz A, Tan NS, Zhu Y, Sutterwala FS, Shen X, Zhang W. Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene. 2019 Mar; 38 (13):2351-2363 Epub 2018 Dec 05
    View PubMed
  40. Heinzman JT, Hoth KF, Cho MH, Sakornsakolpat P, Regan EA, Make BJ, Kinney GL, Wamboldt FS, Holm KE, Bormann N, Robles J, Kim V, Iyer AS, Silverman EK, Crapo JD, Han S, Potash JB, Shinozaki G, COPDGene Investigators. GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort. J Affect Disord. 2019 Jan 15; 243:16-22 Epub 2018 Sept 07
    View PubMed
  41. Reznikov LR, Meyerholz DK, Abou Alaiwa M, Kuan SP, Liao YJ, Bormann NL, Bair TB, Price M, Stoltz DA, Welsh MJ. The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity. Am J Physiol Lung Cell Mol Physiol. 2018 Aug 1; 315 (2):L133-L148 Epub 2018 Apr 05
    View PubMed
  42. Borcherding N, Bormann NL, Voigt AP, Zhang W. TRGAted: A web tool for survival analysis using protein data in the Cancer Genome Atlas. F1000Res. 2018; 7:1235 Epub 2018 Aug 10
    View PubMed
  43. Borcherding N, Bormann N, Kusner D, Kolb R, Zhang W. Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer. Genom Data. 2015 Jun 1; 4:119-122
    View PubMed
  44. Han R, Ha JW, Xiao C, Pei Y, Qi Z, Dong B, Bormann NL, Huang W, Fang N. Geometry-assisted three-dimensional superlocalization imaging of single-molecule catalysis on modular multilayer nanocatalysts. Angew Chem Int Ed Engl. 2014 Nov 17; 53 (47):12865-9 Epub 2014 Sept 26
    View PubMed